Pembrolizumab and Involved Site Radiation Therapy for Early Stage Relapsed or Primary Refractory Hodgkin Lymphoma
Clinical trial NCT03179917 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03179917
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-08
- Primary completion
- 2026-06-15
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.